InvestorsHub Logo
Followers 120
Posts 20685
Boards Moderated 0
Alias Born 06/13/2011

Re: rosemountbomber post# 1539

Tuesday, 11/09/2021 2:11:38 PM

Tuesday, November 09, 2021 2:11:38 PM

Post# of 1569
Rose ...that was a preplanned sale
Still like CYTK more than AMRN, AUPH, AXSM at these levels .... they are presenting at AHA

We need the infringement case to proceed for AMRN to move. Auto switching at pharmacies are killing their script numbers .
AUPH ...market is for severe LN .. about 10% of those with LN imho . Stock will drop at least 20% if they GIA.
AXSM ...looked like a down grade today ? The earning report was OK but I didn't like them saying they needed weeks to months to cure the deficiencies raised by the FDA ...if I heard that correctly

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced two presentations at the American Heart Association (AHA) Scientific Sessions 2021, taking place online from November 13, 2021 – November 15, 2021, including the presentation of additional results from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure) assessing the effect of omecamtiv mecarbil on stroke in patients with heart failure with reduced ejection fraction (HFrEF), and the presentation of preclinical data relating to a cardiac troponin activator that is a closely related analog to CK-3828136 (CK-136).[/quote]

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News